FVIII gene therapy using retroviral vector has promise

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1412, 2003-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Retroviral Vector-mediated Gene Therapy for Metabolic Diseases: An Update

By  

Current Pharmaceutical Design, Vol. 17, Iss. 24, 2011-08 ,pp. : 2516-2527

Bentham Science Publishers

Access to resources Recommend Favorite

Biosafety Considerations Using Gamma-Retroviral Vectors in Gene Therapy

By  

Current Gene Therapy, Vol. 13, Iss. 6, 2013-12 ,pp. : 469-477

Bentham Science Publishers

Access to resources Recommend Favorite

Current Advances in Retroviral Gene Therapy

By  

Current Gene Therapy, Vol. 11, Iss. 3, 2011-06 ,pp. : 218-228

Bentham Science Publishers

Access to resources Recommend Favorite

Retroviral Gene Therapy: Safety Issues and Possible Solutions

By  

Current Gene Therapy, Vol. 5, Iss. 1, 2005-02 ,pp. : 25-35

Bentham Science Publishers

Access to resources Recommend Favorite

Gene Therapy Using an Adenovirus Vector for Apoptosis-Related Genes is a Highly Effective Therapeutic Modality for Killing Glioma Cells

By  

Current Gene Therapy, Vol. 3, Iss. 2, 2003-04 ,pp. : 147-153

Bentham Science Publishers

Access to resources Recommend Favorite